Biventricular Takotsubo Cardiomyopathy Secondary to COVID-19.
| Autor: | Casey B 3rd; Internal Medicine, Cape Fear Valley Medical Center, Fayetteville, USA., Chen G; Internal Medicine, Cape Fear Valley Medical Center, Fayetteville, USA., Bahekar A; Cardiology, Cape Fear Valley Medical Center, Fayetteville, USA., Patel D; Cardiology, Cape Fear Valley Medical Center, Fayetteville, USA., Guddeti R; Cardiovascular Medicine, Creighton University School of Medicine, Omaha, USA. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Cureus [Cureus] 2023 Mar 14; Vol. 15 (3), pp. e36153. Date of Electronic Publication: 2023 Mar 14 (Print Publication: 2023). |
| DOI: | 10.7759/cureus.36153 |
| Abstrakt: | Takotsubo cardiomyopathy (TCM) is a heart failure syndrome characterized by acute and transient dysfunction of the apical segment of the left ventricle. Since the emergence of coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the diagnosis of TCM has increased in prevalence. Here we present an intriguing case of a patient who initially presented to the hospital with respiratory failure and received a diagnosis of COVID-19. During the patient's hospital course, he was also diagnosed with biventricular TCM and subsequently experienced complete resolution of TCM before discharge. Providers should be cognizant of the potential cardiovascular complications of COVID-19 and consider those heart failure syndromes, including TCM, could be causing some of the respiratory dysfunction in these patients. Competing Interests: The authors have declared that no competing interests exist. (Copyright © 2023, Casey et al.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|